drugset / Trial / NCT07010237
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
NaSingle-groupOpen-labelTreatment
Summary
This is a prospetive,Single-Center, Single-Arm, Phase IIB Clinical Study.This study aims to evaluate the efficacy and safety of dose-attenuated IST combined with Hetrombopag in elderly patients (≥65 years) with VSAA/SAA.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2028-12-31
- Completion
- 2029-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 3 mg/kg | — |
| Subject | Hetrombopag | Small molecule | 15 mg | — |
| Subject | Porcine-ATG | Unknown | 15 mg/kg | Intravenous |